Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
Clinical trial NCT03078010 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03078010
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-10
- Primary completion
- 2027-02-01
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.